Tumor Treating Fields for Mesothelioma Still on Track Amidst COVID-19
|

Tumor Treating Fields for Mesothelioma Still on Track Amidst COVID-19

The company that developed tumor treating fields for mesothelioma says it is still making, supporting, and studying the device in spite of the global pandemic.  Last month, Novocure even announced a new name for the electricity-based mesothelioma therapy. Tumor treating fields or the NovoTTF-100L System will now go by the brand name Optune Lua.  “Optune Lua is easy to pronounce and remember, and should help patients, caregivers and providers ask for the treatment by name,” says Pritesh Shah, Novocure’s Chief Commercial Officer.  Novocure says they are following all WHO and CDC recommendations to keep producing tumor treating fields for mesothelioma patients who need it.  What is Optune Lua? Tumor treating fields for mesothelioma uses specific frequencies of electric fields to…